No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 3.1x · 10Y median 3.4x · 36th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 19
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T12:00:51.002Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T12:00:51.002Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T12:00:51.002Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T12:00:51.002Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T12:00:51.002Z. Latest historical point 2026-10-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T12:00:51.002Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T12:00:51.002Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T12:00:51.002Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Advanced Flower Capital Inc. (AFCG) stock was $3.32 as of Oct 5, 2026, 4:00 PM EDT, down 5.14% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -10.9% · 3-year avg -15.3%/yr · 5-year avg -16.1%/yr
Advanced Flower Capital Inc. originates, structures, underwrites, invests in, and manages senior secured loans and other types of mortgage loans and debt securities for established companies operating in the cannabis industry.
Asset Management · West Palm Beach, FL
Next Earnings Date
Nov 11, 2026
36 days away
EPS Estimate
0.18
Revenue Est.
$8.33M
Last Quarter Results
EPS
$0.15
vs Estimate
$0.19
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1AFCG | $75.73M | $3.32 | -5.14% | -10.92% | -16.14% | N/A | N/A |
| 2BTCS | $75.16M | $1.51 | +5.59% | -70.51% | -23.47% | -20.04% | vs AFCG |
| 3ASRV | $74.98M | $4.42 | -4.84% | +55.46% | +5.91% | +6.22% | vs AFCG |
| 4CPBI | $82.61M | $19.75 | -1.62% | +21.43% | N/A | N/A | vs AFCG |
| 5CLST | $67.87M | $16.75 | +2.76% | +25.80% | N/A | N/A | vs AFCG |
| 6BSAA | $67.78M | $11.25 | -0.44% | +11.88% | N/A | N/A | vs AFCG |
TTM
3.12
$8.69M
vs Estimate
$8.59M
Consensus Rating
Based on 1 analyst
Average Price Target
$8.00
+141.0% upside
Low
$8.00
Current
$3.32
High
$8.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.15 | $0.17 | $0.18 | 2 |
| Quarter ending Dec 2026 | $0.16 | $0.17 | $0.18 | 1 |
| Quarter ending Mar 2027 | $0.17 | $0.18 | $0.18 | 1 |
| Quarter ending Jun 2027 | $0.17 | $0.18 | $0.19 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $0.66 | $0.70 | $0.74 | 1 |
| FY 2027 | $0.71 | $0.74 | $0.76 | 2 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $8.24M | $8.33M | $8.43M | 1 |
| Quarter ending Dec 2026 | $8.12M | $8.48M | $8.84M | 1 |
| Quarter ending Mar 2027 | $8.27M | $8.47M | $8.66M | 1 |
| Quarter ending Jun 2027 | $8.48M | $8.68M | $8.88M | 1 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $33.49M | $34.04M | $34.59M | 1 |
| FY 2027 | $35.08M | $35.32M | $35.54M | 2 |
